Vista Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 1.52 | 3.47 | 2.68 |
Operating Expense | 2.63 | 4.14 | 4.07 |
Net Profit | -1.29 | -1.50 | -1.32 |
Net Profit Margin | -84.87 | -43.23 | -49.25 |
Earning Per Share | -0.22 | -0.79 | -0.07 |
EBIDTA | -0.92 | -0.68 | -0.91 |
Effective Tax Rate | TBA | -64.18 | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 1.52 |
Operating Expense | 2.63 |
Net Profit | -1.29 |
Net Profit Margin | -84.87 |
Earning Per Share | -0.22 |
EBIDTA | -0.92 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 10.07 | 10.29 | 1.00 |
Operating Expenses Annual | 14.10 | 13.60 | 5.45 |
Operating Profit Annual | -3.59 | -3.24 | -4.05 |
Interest Annual | 0.96 | 1.22 | 1.21 |
Depreciation | 0.74 | 0.72 | 0.62 |
Net Profit Annual | -4.65 | -4.51 | -5.66 |
Tax Annual | -0.64 | -0.67 | -0.21 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 10.07 |
Operating Expenses Annual | 14.10 |
Operating Profit Annual | -3.59 |
Interest Annual | 0.96 |
Depreciation | 0.74 |
Net Profit Annual | -4.65 |
Tax Annual | -0.64 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.09 | 0.20 | 0.07 |
Cash Flow from Operations | -6.98 | -4.91 | -1.71 |
Cash Flow from Investing | -0.44 | -0.79 | -1.27 |
Cash Flow from Financing | 8.06 | 5.59 | 3.11 |
Cash Flow at the End | 0.73 | 0.09 | 0.20 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.09 |
Cash Flow from Operations | -6.98 |
Cash Flow from Investing | -0.44 |
Cash Flow from Financing | 8.06 |
Cash Flow at the End | 0.73 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | -35.55 | -31.29 | -392 |
PBIT Margin (%) | -42.90 | -38.29 | -454 |
PBT Margin (%) | 1.29 | -7.39 | -116 |
Net PROFIT Margin (%) | -46.18 | -43.83 | -566 |
Return On Networth / Equity (%) | TBA | TBA | TBA |
Return On Networth /Employed (%) | TBA | TBA | TBA |
Return On Assets (%) | -9.24 | -9.64 | -11.32 |
Total Debt / Equity (X) | 0.18 | 0.23 | 0.31 |
Asset Turnover Ratio (%) | 0.20 | 0.22 | 0.02 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | -35.55 |
PBIT Margin (%) | -42.90 |
PBT Margin (%) | 1.29 |
Net PROFIT Margin (%) | -46.18 |
Return On Networth / Equity (%) | TBA |
Return On Networth /Employed (%) | TBA |
Return On Assets (%) | -9.24 |
Total Debt / Equity (X) | 0.18 |
Asset Turnover Ratio (%) | 0.20 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 18.70 | 19.32 | 19.74 |
Total Current Assets Annual | 24.91 | 23.40 | 23.75 |
Non Current Assets Annual | 35.38 | 34.58 | 32.28 |
Total Shareholders Funds Annual | 45.42 | 40.46 | 36.71 |
Total Assets Annual | 60.29 | 57.98 | 56.03 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 18.70 |
Total Current Assets Annual | 24.91 |
Non Current Assets Annual | 35.38 |
Total Shareholders Funds Annual | 45.42 |
Total Assets Annual | 60.29 |
No Data Availabe